SCHEMBL26621990

SCHEMBL26621990

CCOC(=O)c1cc2c(Br)c(OC)ccc2s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
GAA P10253 2/20 0.50
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47
TUBA1A Q71U36 1/20 0.47
TUBA1C Q9BQE3 1/20 0.47
TUBB6 Q9BUF5 1/20 0.47
TUBB2B Q9BVA1 1/20 0.47
TUBB1 Q9H4B7 1/20 0.47
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9431710 0.86 HDAC1 (0.52) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL26622003 0.85 PTPN2 (0.45) MAPTGAAHDAC3HDAC4HDAC1
SCHEMBL31081197 0.84 MAPT (0.46) MAPTGAAHDAC3HDAC4HDAC1
SCHEMBL31081110 0.83 ERN1 (0.46) MAPTGAATUBB4ATUBBTUBA3C
SCHEMBL31081408 0.82 STING1 (0.45) MAPTGAATUBB4ATUBBTUBA3C
SCHEMBL31081047 0.82 STING1 (0.45) MAPTGAATUBB4ATUBBTUBA3C
SCHEMBL26621970 0.82 HDAC3 (0.50) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL18264039 0.81 HDAC3 (0.64) MAPTGAAHDAC3HDAC4HDAC1
SCHEMBL18069891 0.80 PTPN2 (0.48) MAPTGAAHDAC3HDAC4HDAC1
SCHEMBL31081287 0.79 MAPT (0.43) MAPTGAATUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023214325-A1 PYRAZOLOPYRIMIDINE DERIVATIVES AND USES THEREOF AS TET2 INHIBITORS NOVARTIS AG (CH) 2023-11-09 WO disclosed